Free Trial

Biora Therapeutics (BIOR) SEC Filings & 10K Form

Biora Therapeutics logo
$1.62 0.00 (0.00%)
(As of 11:30 AM ET)

Recent Biora Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
9:01 AM
Biora Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
10/29/2024
3:43 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:37 AM
Biora Therapeutics (Filer)
Form 424B5
10/29/2024
7:28 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:15 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:19 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:21 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:24 AM
Biora Therapeutics (Filer)
Form 424B3
10/23/2024
4:24 PM
Biora Therapeutics (Filer)
Form DEF 14A
10/11/2024
3:52 PM
Biora Therapeutics (Filer)
Form PRE 14A
10/11/2024
7:00 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:40 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
09/16/2024
3:30 PM
Biora Therapeutics (Filer)
Form DEF 14A
09/13/2024
9:37 AM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
09/05/2024
5:02 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
09/03/2024
3:31 PM
Biora Therapeutics (Filer)
Form PRE 14A
08/23/2024
4:06 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:08 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:11 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:13 PM
Biora Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/23/2024
4:03 PM
Biora Therapeutics (Filer)
Form 424B5
08/21/2024
4:00 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:15 PM
Biora Therapeutics (Subject)
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
Form SC 13G
08/14/2024
8:57 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
8:58 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
08/12/2024
3:30 PM
Biora Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:15 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:05 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
8:42 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
07/08/2024
8:15 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
8:00 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
7:21 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
5:04 AM
Biora Therapeutics (Filer)
Form 424B5
07/01/2024
5:07 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:30 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:31 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Howe Jill Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Alter Jeffrey D. (Reporting)
Biora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Kotzin Brian L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
06/02/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
06/02/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
04/24/2024
3:06 PM
Biora Therapeutics (Filer)
Form DEFA14A
04/24/2024
3:11 PM
Biora Therapeutics (Filer)
Form ARS
04/17/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
04/12/2024
3:30 PM
Biora Therapeutics (Filer)
Form PRE 14A
04/02/2024
7:43 PM
Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
04/02/2024
3:44 PM
Biora Therapeutics (Filer)
Form 424B5
04/02/2024
3:46 PM
Biora Therapeutics (Filer)
Form 424B5
04/02/2024
3:48 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:45 PM
Biora Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:10 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
5:29 PM
Biora Therapeutics (Subject)
Context Capital Management, LLC (Filed by)
Form SCHEDULE 13G
03/11/2024
7:11 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
Biora Therapeutics (Subject)
Form SC 13G/A
01/16/2024
4:20 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/01/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
12/22/2023
4:19 PM
Biora Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/20/2023
3:29 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:35 PM
Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
12/18/2023
7:06 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
4:25 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
5:06 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIOR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners